CRLC Val d'Aurelle - Paul Lamarque

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Bladder cancer1 trial
• Lung cancer1 trial

Phase

• Phase 31 trial

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• Institut du Cancer de Montpellier - Val d'Aurelle1 trial
• Takeda1 trial

Closed trials

• Completed

  TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

  NCT04129502· Phase 3· Takeda· Source

• Terminated

  A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer

  NCT01495676· Institut du Cancer de Montpellier - Val d'Aurelle· Source